Literature DB >> 34506030

Microscopic Portal Vein Invasion in Relation to Tumor Focality and Dimension in Patients with Hepatocellular Carcinoma.

Brian I Carr1, Vito Guerra2, Rossella Donghia2, Volkan Ince1, Sami Akbulut3, Veysel Ersan1, Sertac Usta1, Burak Isik1, Emine Samdanci4, Sezai Yilmaz1.   

Abstract

BACKGROUND: Microscopic portal vein invasion (microPVI) and tumor multifocality are hepatocellular carcinoma (HCC) prognosis factors. To investigate whether microPVI and multifocality are directly related to each other.
METHODS: We retrospectively analyzed the relationships between microPVI, multifocality, and maximum tumor diameter (MTD) in prospectively collected transplanted HCC patients.
RESULTS: HCCs with 1, 2, or ≥ 3 foci had more microPVI in larger than in smaller HCCs, with microPVI being present in 52.24% of single large foci. Conversely, microPVI patients had similar percentages of single and multifocal lesions. A linear regression model of MTD, showed microPVI best associated with MTD, with 2.49 as coefficient, whereas multifocality had a 0.83 coefficient. A logistic regression model of microPVI showed significant association with tumor multifocality, especially for small HCCs. Trends for microPVI and multifocality in relation to MTD revealed that both increased with MTD but more significantly for microPVI. Survival was similar in patients with small HCCs, with or without microPVI, but was significantly worse in microPVI patients with larger HCCs. No patient survival differences were found in relation to focality.
CONCLUSIONS: MTD had stronger associations with microPVI than with multifocality. microPVI was associated with worse survival in patients with large HCCs, but survival was not impacted by number of tumor foci. microPVI and multifocality appear weakly related, having different behavior in relation to MTD and survival.
© 2021. The Society for Surgery of the Alimentary Tract.

Entities:  

Keywords:  Focality; Hepatocellular carcinoma; Microscopic portal vein invasion; Survival

Mesh:

Year:  2021        PMID: 34506030     DOI: 10.1007/s11605-021-05126-7

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  32 in total

1.  Validation of a Liver Index and Its Significance for HCC Aggressiveness.

Authors:  Brian I Carr; Vito Guerra
Journal:  J Gastrointest Cancer       Date:  2017-09

2.  Risk factors of microvascular invasion, portal vein tumor thrombosis and poor post-resectional survival in HBV-related hepatocellular carcinoma.

Authors:  Li Zhou; Jing-An Rui; Shao-Bin Wang; Shu-Guang Chen; Qiang Qu
Journal:  Hepatogastroenterology       Date:  2014-09

Review 3.  Molecular therapies and precision medicine for hepatocellular carcinoma.

Authors:  Josep M Llovet; Robert Montal; Daniela Sia; Richard S Finn
Journal:  Nat Rev Clin Oncol       Date:  2018-10       Impact factor: 66.675

4.  Characteristics of Hepatocellular Carcinoma Aggressiveness Factors in Turkish Patients.

Authors:  Hikmet Akkiz; Brian I Carr; Kendal Yalçın K; Vito Guerra; Sedef Kuran; Engin Altıntaş; Oğuz Üsküdar; Ümit Karaoğullarından; Ayşegül Özakyol; Salih Tokmak; Mehmet Yücesoy; Halil İbrahim Bahçeci; Abdulalh Ülkü; Tolga Akçam; Kamil Yalçın Polat; Nazım Ekinci; Halis Şimşek; Necati Örmeci; Abdulalh Sonsuz; Mehmet Demir; Murat Kılıç; Ahmet Uygun; Tuğsan Ballı; Ali Demir; Burcu Arslan; Figen Doran
Journal:  Oncology       Date:  2017-12-06       Impact factor: 2.935

5.  Clinicopathologic characteristics and surgical outcomes of hepatocellular carcinoma with portal vein tumor thrombosis.

Authors:  Jing-Song Chen; Qian Wang; Xi-Lin Chen; Xiao-Hui Huang; Li-Jian Liang; Jian Lei; Jiong-Qiang Huang; Dong-Ming Li; Zhi-Xiang Cheng
Journal:  J Surg Res       Date:  2011-04-24       Impact factor: 2.192

6.  Prognostic role of tumor mutation burden in hepatocellular carcinoma after radical hepatectomy.

Authors:  Huayong Cai; Yu Zhang; Haoyun Zhang; Chao Cui; Chonghui Li; Shichun Lu
Journal:  J Surg Oncol       Date:  2020-01-29       Impact factor: 3.454

7.  A Hepatocellular Carcinoma Aggressiveness Index and Its Relationship to Liver Enzyme Levels.

Authors:  Brian I Carr; Vito Guerra
Journal:  Oncology       Date:  2016-03-15       Impact factor: 2.935

8.  Incidence of microsatellite instability-high hepatocellular carcinoma among Japanese patients and response to pembrolizumab.

Authors:  Tomokazu Kawaoka; Yuwa Ando; Masami Yamauchi; Yosuke Suehiro; Kenji Yamaoka; Yumi Kosaka; Yasutomo Fuji; Shinsuke Uchikawa; Kei Morio; Hatsue Fujino; Takashi Nakahara; Atsushi Ono; Eisuke Murakami; Shoichi Takahashi; Masataka Tsuge; Akira Hiramatsu; Michio Imamura; Kazuaki Chayama; Hiroshi Aikata
Journal:  Hepatol Res       Date:  2020-03-06       Impact factor: 4.288

9.  A Liver Index and its Relationship to Indices of HCC Aggressiveness.

Authors:  Brian I Carr; Vito Guerra; Edoardo G Giannini; Fabio Farinati; Francesca Ciccarese; Gian Ludovico Rapaccini; Maria Di Marco; Luisa Benvegnù; Marco Zoli; Franco Borzio; Eugenio Caturelli; Alberto Masotto; Franco Trevisani
Journal:  J Integr Oncol       Date:  2016-09-05

10.  Intratumoral heterogeneity and clonal evolution in liver cancer.

Authors:  Bojan Losic; Amanda J Craig; Carlos Villacorta-Martin; Sebastiao N Martins-Filho; Nicholas Akers; Xintong Chen; Mehmet E Ahsen; Johann von Felden; Ismail Labgaa; Delia DʹAvola; Kimaada Allette; Sergio A Lira; Glaucia C Furtado; Teresa Garcia-Lezana; Paula Restrepo; Ashley Stueck; Stephen C Ward; Maria I Fiel; Spiros P Hiotis; Ganesh Gunasekaran; Daniela Sia; Eric E Schadt; Robert Sebra; Myron Schwartz; Josep M Llovet; Swan Thung; Gustavo Stolovitzky; Augusto Villanueva
Journal:  Nat Commun       Date:  2020-01-15       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.